Long-term follow-up of platelet-rich plasma injections for refractory lateral epicondylitis.
case_series · Level IV
Where this comes from
- Record sourced from PubMed, PMID 31680739.
- Also identified by DOI 10.1016/j.jor.2019.08.023 and PMC identifier 6818374.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Lateral epicondylitis (LE)<sup>1</sup> affects between 1 and 3% of the population. Recently, platelet-rich plasma (PRP)<sup>2</sup> has gained popularity. Assess the long-term outcomes of PRP for patients with refractory LE. We assessed 31 patients who had failed conservative management using the Oxford Elbow Score (OES).<sup>3</sup>. Mean follow-up: 5.2 years (range 4.2-6.1 years).87.1% exhibited minimum clinically important difference (MCID)<sup>4</sup> in pain scores between pre-op and long-term. 90.3% displayed MCID in function and psycho-social domains.Two patients had a repeat injection and six underwent open release. PRP is successful in treating refractory LE in most patients and avoiding surgery.